Scotland bolsters health plan with first HTA (health technology assessment) schedule
This article was originally published in Clinica
Executive Summary
Positron emission tomography (PET) scanning for cancer, and the organisation of screening services for diabetic retinopathy, are among the first topics to be assessed by the Health Technology Board for Scotland (HTBS). Specific areas to be addressed in each of the planned topics will be assessed early in the clinical- and cost-effectiveness assessment process, it says.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.